LiberaBio is rated 3 out of 5 in the category biotechnology. Read and write reviews about LiberaBio. LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins.
Company size
1-10 employees
Headquarters
Santiago de Compostela, Galicia